SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-20-006918
Filing Date
2020-03-20
Accepted
2020-03-19 21:31:45
Documents
4
Period of Report
2020-01-06
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM 8-K ea119633-8ka_artaratherap.htm 8-K/A 24654
2 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ea119633ex23-1_artaratherap.htm EX-23.1 1998
3 AUDITED FINANCIAL STATEMENTS OF ARTARA SUBSIDIARY, INC. AS OF DECEMBER 31, 2019 ea119633ex99-1_artaratherap.htm EX-99.1 266935
4 UNAUDITED PRO FORMA COMBINED FINANCIAL STATEMENTS ea119633ex99-2_artaratherap.htm EX-99.2 199777
  Complete submission text file 0001213900-20-006918.txt   494525
Mailing Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014
Business Address 1 LITTLE WEST 12TH STREET NEW YORK NY 10014 646-844-0337
ArTara Therapeutics, Inc. (Filer) CIK: 0001359931 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36694 | Film No.: 20730030
SIC: 2836 Biological Products, (No Diagnostic Substances)